OnKure Therapeutics, Inc. 8-K

What Happened
On March 12, 2026, OnKure Therapeutics, Inc. (ticker: OKUR) announced and furnished a press release reporting its financial results for the quarter and year ended December 31, 2025. The press release is attached to the Form 8‑K as Exhibit 99.1 and is incorporated by reference into the Form 8‑K filing.

Key Details

• Press release reporting quarterly and full-year 2025 financial results was issued on March 12, 2026 and is attached as Exhibit 99.1.
• The results cover the quarter and fiscal year ended December 31, 2025 (Q4 and FY2025).
• The Exhibit is furnished, not filed; the company states the furnished information is not subject to Section 18 liability and is not automatically incorporated by reference into other registration statements or filings under the Securities Act or Exchange Act.
• Investors should review Exhibit 99.1 (the press release) for specific figures on earnings, revenue, cash position, and other financial metrics.

Why It Matters
Earnings and quarterly results are primary drivers of investor decisions—this filing directs investors to the company’s official summary of its financial performance for Q4 and FY2025. Because the press release is furnished rather than filed, it provides timely disclosure of results but carries different legal treatment (limited Section 18 liability and not presumptively incorporated into future filings). Investors should read Exhibit 99.1 for the detailed revenue, net income/loss, and other metrics that affect valuation and outlook.